Overview

A Study to Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics

Status:
Completed
Trial end date:
2018-08-17
Target enrollment:
Participant gender:
Summary
This study use a single-center, randomized, open, three-cycle, self-control trial design. It is planning to enroll 15 healthy adult male subjects. Fifteen subjects will randomize into 3 test groups which corresponding to 3 different dosing sequences. Subjects will be giving a single oral dose in per cycle, and there will have three types of breakfast administration after each treatment. Washing period is 10 days during the cycle.
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.